The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience.
Abstract
PURPOSE: To determine the incidence of clinical cardiotoxicity from anthracycline chemotherapy in children with cancer and to identify associated risk factors. PATIENTS AND METHODS: The study population consisted of 6,493 children with cancer who had received anthracycline chemotherapy on Pediatric Oncology Group (POG) protocols from 1974 to 1990. Cardiotoxicity, defined as congestive heart failure not due to other causes, abnormal measurements of cardiac function that prompted discontinuation of therapy, or sudden death from presumed cardiac causes, was determined by a review of protocol records. RESULTS: Cardiotoxicity was confirmed in 106 patients (1.6%): 58 had congestive heart failure, 43 had changes in measures of cardiac function that prompted the discontinuation of therapy, and five died suddenly from presumed cardiac causes. In a multivariate analysis, factors that contributed to the relative risk (RR) of toxicity were a cumulative anthracycline dose > or = 550 mg/m2 of body-surface area (RR = 5.2), maximal dose > or = 50 mg/m2 (RR = 2.8), female sex (RR = 1.9), black race (RR = 1.7), presence of trisomy 21 (RR = 3.4), and exposure to amsacrine (RR = 2.6). Cardiotoxicity within 1 year after the completion of anthracycline treatment (early cardiotoxicity) represented 89.5% of all cases. CONCLUSION: Early clinical cardiotoxicity in children treated with anthracycline is rare. A high maximal dose, or cumulative dose of anthracycline, female sex, black race, presence of trisomy 21, and treatment with amsacrine increase the risk for anthracycline-associated cardiotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood
Lipshultz, S. E., Colan, S. D., Gelber, R. D., Perez-Atayde, A. R., Sallan, S. E., & Sanders, S. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241205 · Cited by 1,404
Self-citationDangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
Altman, D. G., Lausen, B., Sauerbrei, W., & Schumacher, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.11.829 · Cited by 1,143
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470120074036 · Cited by 989
Lipshultz, S. E., Lipsitz, S. R., Mone, S. M., Goorin, A. M., Sallan, S. E., Sanders, S. P., Orav, E. J., Gelber, R. D., & Colan, S. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322602 · Cited by 803
Self-citationCardiovascular Health and Disease in Women
Wenger, N. K., Speroff, L., & Packard, B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307223290406 · Cited by 801
Polikar, R., Burger, A. G., Scherrer, U., & Nicod, P. (1993) · Circulation · doi:10.1161/01.cir.87.5.1435 · Cited by 475
Triceps skin fold and upper arm muscle size norms for assessment of nutritional status
Frisancho, A. R. (1974) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/27.10.1052 · Cited by 459
Burgert, E. O., Nesbit, M. E., Garnsey, L. A., Gehan, E. A., Herrmann, J., Vietti, T. J., Cangir, A., Tefft, M., Evans, R., & Thomas, P. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1514 · Cited by 380
The impact of childhood cancer on the United States and the world
Bleyer, W. A. (1990) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.40.6.355 · Cited by 368
Doxorubicin clearance in the obese.
Rodvold, K. A., Rushing, D. A., & Tewksbury, D. A. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.8.1321 · Cited by 213
Smith, M. A., Ungerleider, R. S., Horowitz, M. E., & Simon, R. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.20.1460 · Cited by 202
Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults
Larsen, R. L., Jakacki, R. I., Vetter, V. L., Meadows, A. T., Silber, J. H., & Barber, G. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91393-i · Cited by 197
Sleep related upper airway obstruction in a cohort with Down's syndrome.
Stebbens, V. A., Dennis, J., Samuels, M. P., Croft, C. B., & Southall, D. P. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.11.1333 · Cited by 169
Goorin, A. M., Chauvenet, A. R., Perez-Atayde, A. R., Cruz, J., McKone, R., & Lipshultz, S. E. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81668-3 · Cited by 163
Self-citationKlewer, S. E., Goldberg, S. J., Donnerstein, R. L., Berg, R. A., & Hutter, J. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90497-b · Cited by 133
Cardiac function in Wilms' tumor survivors.
Sørensen, K. E., Levitt, G., Sebag‐Montefiore, D., Bull, C., & Sullivan, I. D. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1546 · Cited by 95
Levine, O. R., & Simpser, M. (1982) · Clinical Pediatrics · doi:10.1177/000992288202100104 · Cited by 91
THE EPIDEMIOLOGY OF IDIOPATHIC DILATED CARDIOMYOPATHY IN A BIRACIAL COMMUNITY
Coughlin, S. S., Szklo, M., Baughman, K. L., & Pearson, T. A. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115484 · Cited by 63
Cardiac dysfunction late after cardiotoxic therapy for childhood cancer
Leandro, J., Dyck, J. D., Poppe, D., Shore, R. M., Airhart, C., Greenberg, M., Gilday, D. L., Smallhorn, J. F., & Benson, L. N. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90470-7 · Cited by 47
Coughlin, S. S., Labenberg, J. R., & Tefft, M. C. (1993) · Epidemiology · doi:10.1097/00001648-199303000-00013 · Cited by 38
Coughlin, S. S., Gottdiener, J. S., Baughman, K. L., Wasserman, A. G., Marx, E. S., Tefft, M. C., & Gersh, B. J. (1994) · PubMed Central · Cited by 31
Cited by
Carver, J. R., Shapiro, C. L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K. S., Hagerty, K. L., Somerfield, M. R., & Vaughn, D. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9777 · Cited by 793
Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 769
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Dalton, V. M., Mone, S. M., Gelber, R. D., & Colan, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.121 · Cited by 727
Self-citationBiology and Therapeutic Advances for Pediatric Osteosarcoma
Marina, N., Gebhardt, M., Teot, L., & Gorlick, R. (2004) · The Oncologist · doi:10.1634/theoncologist.9-4-422 · Cited by 671
Metadata
- Authors
- Krischer, J. P., Epstein, S., Cuthbertson, D. D., Goorin, A. M., Epstein, M. L., & Lipshultz, S. E.
- Venue
- Journal of Clinical Oncology
- Published
- 1997-04
- Volume
- 15
- Issue
- 4
- Pages
- 1544-1552
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1949633840
- Cited by
- 476
- References
- 25
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.